surmount-1 trial tirzepatide weight loss non-diabetic obesity SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes For the first time, tirzepatide – surmount-1 trial tirzepatide non-diabetic obesity

Diabetes Care (2009) 32(7):122430

You are just one consultation away from giving your skin the greatest care possible

The timing of a dose change plays a key role in managing appetite, ensuring comfort, and maintaining steady metabolic improvements

Monthly clinician check-in adjustments as needed Simple refills ships with a few clicks in your Remedy dashboard Pause, adjust, or cancel anytime Unlimited video calls & messaging between check-ins Take 90 seconds 100% private free New

Todorova V, Blokland A

It must be taken on an empty stomach, first thing in the morning, with no more than four ounces of plain water